Chronic Lymphocytic Leukemia
Showing NaN - NaN of 25
Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)
Active, not recruiting
- Anemia
- +2 more
- Cyclophosphamide
- +6 more
-
Birmingham, Alabama
- +795 more
Jan 28, 2023
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +11 more
- Zilovertamab vedotin
-
Duarte, California
- +13 more
Jan 12, 2023
Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic
Recruiting
- Atrial Fibrillation
- +4 more
- Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
-
New Hyde Park, New YorkNorthwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +3 more
-
Boston, Massachusetts
- +11 more
Nov 23, 2022
Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (tafasitamab, parsaclisib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Non Hodgkin Lymphoma
-
Birmingham, Alabama
- +49 more
Sep 21, 2022
Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Post-Chlorambucil Therapy Follow-up
- +4 more
-
Duarte, California
- +106 more
Aug 6, 2021
Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,
Completed
- Indolent Non-Hodgkin's Lymphoma
- +2 more
- Idelalisib
- +8 more
-
Huntsville, Alabama
- +10 more
Feb 22, 2021
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)
Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)
Terminated
- Chronic Lymphocytic Leukemia
- Lymphoma, Non-Hodgkin
-
Huntsville, Alabama
- +17 more
Aug 22, 2019
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)
Terminated
- Chronic Lymphocytic Leukemia
-
Huntsville, Alabama
- +44 more
Aug 12, 2019
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Placebo to match idelalisib)
Collecting and Storing Malignant, Borderline Malignant
Completed
- Acute Undifferentiated Leukemia
- +13 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +191 more
Jul 17, 2018
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Chlorambucil)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Duarte, California
- +107 more
Nov 27, 2017
Chronic Lymphocytic Leukemia Trial in New Hyde Park (Campath)
Terminated
- Chronic Lymphocytic Leukemia
-
New Hyde Park, New YorkLong Island Jewish Medical Center
Sep 16, 2015
Chronic Lymphocytic Leukemia Trial in United States (Talabostat mesylate (PT-100) tablets, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
- Talabostat mesylate (PT-100) tablets
- Rituximab
-
Little Rock, Arkansas
- +18 more
Mar 24, 2015
Chronic Lymphocytic Leukemia Trial in New Hyde Park, Columbus, Nashville (Dasatinib, Combination of Bendamustine + Dasatinib)
Withdrawn
- Chronic Lymphocytic Leukemia
- Dasatinib
- Combination of Bendamustine + Dasatinib
-
New Hyde Park, New York
- +2 more
Jul 19, 2013
Chronic Lymphocytic Leukemia Trial in Washington, Buffalo, New Hyde Park (Oblimersen-rituximab-fludarabine)
Completed
- Chronic Lymphocytic Leukemia
-
Washington, District of Columbia
- +2 more
Nov 4, 2011
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
Completed
- Chronic Lymphocytic Leukemia
-
San Diego, California
- +4 more
Feb 25, 2011
Chronic Lymphocytic Leukemia, CLL, Untreated Trial in United States (Lenalidomide and Rituximab)
Unknown status
- Chronic Lymphocytic Leukemia
- +5 more
- Lenalidomide and Rituximab
-
La Jolla, California
- +4 more
Sep 8, 2010
Chronic Lymphocytic Leukemia, CLL Trial in New Hyde Park, Houston, San Antonio (Oblimerson sodium, G3139)
Completed
- Chronic Lymphocytic Leukemia
- CLL
- Oblimerson sodium, G3139
-
New Hyde Park, New York
- +2 more
Nov 10, 2009
Chronic Lymphocytic Leukemia Trial in Palo Alto, New Hyde Park (Iodine-131 Anti-B1 Antibody)
Unknown status
- Chronic Lymphocytic Leukemia
- Iodine-131 Anti-B1 Antibody
-
Palo Alto, California
- +1 more
Jun 23, 2005